News | Health & Safety
22 Oct 2017 1:12
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Ski Report
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     21 Oct: Woman charged over Auckland stabbing
     21 Oct: Mental health a top priority in Canterbury
     20 Oct: Shares rise as weak dollar helps companies
     20 Oct: More drinking fountains to tackle obesity
     17 Oct: Mums reminded about iodine, folic acid
     16 Oct: Man, 78, dies after four-day surgery wait
     16 Oct: Waikato DHB appoints new boss
     Top Stories

    RUGBY RUGBY
    Tasman set up NPC final with Canterbury More...


    BUSINESS BUSINESS
    Shares rise as weak dollar helps companies More...



     Today's News

    Rugby:
    Tasman set up NPC final with Canterbury 21:57

    International:
    ASX rebound: What is behind it and can it last? 21:37

    International:
    'It's about bloody time': Period 'blood' shown in advertisement in effort to confront taboos 21:17

    Rugby:
    Canterbury too good for Harbour in semi 21:17

    Auckland:
    Person critical after New Lynn crash 18:57

    Golf:
    Brown well-placed at WA Open in Perth 18:37

    Rugby:
    Heartland Championship finalists found 18:07

    Accident and Emergency:
    Four people fall from balcony at hotel 17:27

    Rugby:
    Steamers outlast Otago for finals spot 16:57

    Soccer:
    Glory and Mariners hunt first A-League win 16:17


     News Search






    Power Search


    © 2017 New Zealand City Ltd